7498 Results (Page 197 of 300)
Pharmaceuticals Markets Research Reports
Egypt Antibacterial (Antibiotics) Drugs Market Analysis
Egypt Antibacterial (Antibiotics) Drugs Market is at around $0.14 Bn in 2023 and is projected to reach $0.21 Bn in 2030, exhibiting a CAGR of 5.7% during the forecast period. Governmental initiatives and regulations, the prevalence of infectious diseases, and rising healthcare spending are some of the factors driving the market. The market is dominated by key players like Eva Pharma, Pfizer Inc., AbbVie (Allergan), Roche, Novartis AG, GlaxoSmithKline plc, Abbott Laboratories, Johnson & Johnson, Merck & Co., Inc., and Sanofi S.A.
Vietnam Antibacterial (Antibiotics) Drugs Market Analysis
Vietnam Antibacterial (Antibiotics) Drugs Market is at around $0.25 Bn in 2023 and is projected to reach $0.34 Bn in 2030, exhibiting a CAGR of 4.43% during the forecast period. The market is being driven by factors such as medical tourism, pharmaceutical industry expansion, urbanization, and changing lifestyles. The market is dominated by key players like Traphaco, Mekophar, Hau Giang Pharmaceuticals, Pfizer Inc., AbbVie (Allergan), Roche, Novartis AG, GlaxoSmithKline plc, Abbott Laboratories, Johnson & Johnson, and Merck & Co., Inc.
Singapore Antibacterial (Antibiotics) Drugs Market Analysis
Singapore Antibacterial (Antibiotics) Drugs Market is at around $61.09 Mn in 2023 and is projected to reach $84.82 Mn in 2030, exhibiting a CAGR of 4.8% during the forecast period. The market is expanding due to factors such as increasing population and urbanization, the development of healthcare infrastructure, and awareness initiatives and education. The market is dominated by key players like Biostadt Pharmaceuticals Pte Ltd, Pfizer Inc., AbbVie (Allergan), Roche, Novartis AG, GlaxoSmithKline plc, Abbott Laboratories, Johnson & Johnson, Merck & Co., Inc., Sanofi S.A., and Teva Pharmaceuticals Industries Ltd.
Philippines Antibacterial (Antibiotics) Drugs Market Analysis
Philippines Antibacterial (Antibiotics) Drugs Market is at around $0.11 Bn in 2023 and is projected to reach $0.15 Bn in 2030, exhibiting a CAGR of 4.7% during the forecast period. The market's growth is being driven by rising spending on healthcare, the prevalence of infectious diseases, and population growth. The market is dominated by key players like Unilab, Pascual Laboratories, Inc., Pfizer Inc., AbbVie (Allergan), Roche, Novartis AG, GlaxoSmithKline plc, Abbott Laboratories, Johnson & Johnson, Merck & Co., Inc., and Sanofi S.A.
Malaysia Antibacterial (Antibiotics) Drugs Market Analysis
Malaysia Antibacterial (Antibiotics) Drugs Market is at around $81.45 Mn in 2023 and is projected to reach $110.11 Mn in 2030, exhibiting a CAGR of 4.4% during the forecast period. The market is driven by rising rates of infectious diseases, expanding healthcare infrastructure and awareness, and technological advancements. The market is dominated by key players like Duopharma Biotech Bhd, Pharmaniaga Bhd, Ltd., Pfizer Inc., Roche, Novartis AG, GlaxoSmithKline plc, Abbott Laboratories, Johnson & Johnson, Merck & Co., Inc., and Sanofi S.A.
Japan Antibacterial (Antibiotics) Drugs Market Analysis
Japan Antibacterial (Antibiotics) Drugs Market is at around $3.16 Bn in 2023 and is projected to reach $4.36 Bn in 2030, exhibiting a CAGR of 4.7% during the forecast period. The market is growing as a result of the aging population, rising infectious disease prevalence, and technological advancements in antibiotics. The market is dominated by key players like Mitsubishi Chemical Group Corporation, Sumitomo Dainippon Pharma Co., Ltd., Pfizer Inc., Roche, Novartis AG, GlaxoSmithKline plc, Abbott Laboratories, Johnson & Johnson, Merck & Co., Inc., and Sanofi S.A.
Indonesia Antibacterial (Antibiotics) Drugs Market Analysis
Indonesia Antibacterial (Antibiotics) Drugs Market is at around $0.31 Bn in 2023 and is projected to reach $0.41 Bn in 2030, exhibiting a CAGR of 4.2% during the forecast period. The market is driven by rising infectious disease rates, improving healthcare infrastructure, and rising healthcare awareness. The market is dominated by key players like Kalbe Farma, Kimia Farma, Pfizer Inc., Roche, Novartis AG, GlaxoSmithKline plc, Abbott Laboratories, Johnson & Johnson, Merck & Co., Inc., and Sanofi S.A.
China Antibacterial (Antibiotics) Drugs Market Analysis
China Antibacterial (Antibiotics) Drugs Market is at around $4.09 Bn in 2023 and is projected to reach $6.03 Bn in 2030, exhibiting a CAGR of 5.7% during the forecast period. The market is growing as a result of factors such as rising healthcare expenditures, improving healthcare infrastructure, and an increase in the incidence of infectious diseases. The market is dominated by key players like China Resources Pharmaceutical Group (CR Pharma), Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Jiangsu Hengrui, Pfizer Inc., Roche, Novartis AG, GlaxoSmithKline plc, Abbott Laboratories, Johnson & Johnson, Merck & Co., Inc., and Sanofi S.A.
US Anemia Therapeutics Market Analysis
The US Anemia Therapeutics Market is anticipated to experience a growth from $6.216 Bn in 2022 to $10.76 Bn by 2030, with a CAGR of 7.1% during the forecast period of 2022-2030. Growing healthcare expenditures, favourable government and insurance policies, breakthroughs in treatment choices, and increased awareness campaigns that promote early diagnosis and individualized care all drive the US Anemia Therapeutics Market. The US Anemia Therapeutics Market encompasses various players across different segments, including Amgen, Pfizer, Roche, Sanofi, Novartis, Celgene, Blueprint Medicines, Janus Pharmaceuticals, Pharmacosmos, Apotex etc, among various others.
UK Anemia Therapeutics Market Analysis
The UK Anemia Therapeutics Market is anticipated to experience growth from $385 Mn in 2022 to $666 Mn by 2030, with a CAGR of 7.1% during the forecast period of 2022-2030. The UK Anemia Therapeutics Market is driven by a number of factors, including an aging population with a rising prevalence of chronic illnesses, especially in pregnant women, the National Health Service's emphasis on affordable and easily accessible treatments, and continuous technological advancements. The UK Anemia Therapeutics Market encompasses various players across different segments, including Pfizer, Roche, GlaxoSmithKline (GSK), Novartis, Johnson & Johnson, Shield Therapeutics, Advanz Pharmaceutical, Hikma Pharmaceuticals, Amgen, Vifor Pharma, etc, among various others.
UAE Anemia Therapeutics Market Analysis
The UAE Anemia Therapeutics Market is anticipated to experience a growth from $74 Mn in 2022 to $160 Mn by 2030, with a CAGR of 10.10% during the forecast period of 2022-2030. The UAE Anemia Therapeutics Market is driven by increased government efforts, research investments, pharmaceutical and delivery system advancements, increased healthcare awareness, and growing per capita income. The UAE Anemia Therapeutics Market encompasses various players across different segments, including Amgen, Roche, Novartis, Eli Lilly, GlycoMimetics, Apellis Pharmaceuticals, Life Pharma, Neo Pharma, New Bridge Pharmaceuticals, Sahara Pharmaceuticals, etc, among various others
Spain Anemia Therapeutics Market Analysis
The Spain Anemia Therapeutics Market is anticipated to experience a growth from $286 Mn in 2022 to $533 Mn by 2030, with a CAGR of 8.1 % during the forecast period of 2022-2030. The Spain Anemia Therapeutics Market encompasses various players across different segments, including Amgen, AbbVie, Roche, Pfizer, AstraZeneca, Merck & Co., Arafarma Group, Rolabo Outsourcing, Elli Lily, Persan Pharma etc, among various others.
South Africa Anemia Therapeutics Market Analysis
The South Africa Anemia Therapeutics Market is anticipated to experience a growth from $96 Mn in 2022 to $211 Mn by 2030, with a CAGR of 10.33% during the forecast period of 2022-2030. The expansion of the therapeutics market is driven by the elevated prevalence of anemia in women and children, stemming from factors like chronic diseases, nutritional deficits, and government efforts aimed at fortification, supplementation, and improved accessibility to cost-effective pharmaceuticals. The South Africa Anemia Therapeutics Market encompasses various players across different segments, including Sanofi, AstraZeneca, Pfizer, AbbVie, Pharmacosmos, AMAG Pharmaceuticals, Roche, Novartis, Adcock Ingram, Aspen Pharmacare etc, among various others.
Singapore Anemia Therapeutics Market Analysis
The Singapore Anemia Therapeutics Market is anticipated to experience a growth from $18 Mn in 2022 to $37 Mn by 2030, with a CAGR of 9.7% during the forecast period of 2022-2030. The Singapore Anemia Therapeutics Market is driven by rising prevalence, expanding awareness, evolving treatments, a robust healthcare system, and regional demand, though limited population and affordability hurdles remain. The Singapore Anemia Therapeutics Market encompasses various players across different segments, including Novartis, Pfizer, AbbVie, Roche, Sanofi, AstraZeneca, Bristol-Myers Squibb, Zuellig Pharma, DKSH, Pharmaniaga etc, among various others.
Saudi Arabia Anemia Therapeutics Market Analysis
The Saudi Arabia Anemia Therapeutics Market is anticipated to experience a growth from $252 Mn in 2022 to $563 Mn by 2030, with a CAGR of 10.6% during the forecast period of 2022-2030. Certain predisposing circumstances, such as increased prevalence of anemia due to demographic, genetic, and geographical factors, a developing economy, and changing lifestyles, all contribute to the market's growth. The Saudi Arabia Anemia Therapeutics Market encompasses various players across different segments, including Vifor Pharma, Amgen, Roche, Novartis, Takeda Pharmaceuticals, Eli Lilly, Sanofi, Hikma Pharmaceuticals, Tabuk Pharmaceuticals, Julphar etc, among various others.
Philippines Anemia Therapeutics Market Analysis
The Philippines Anemia Therapeutics Market is anticipated to experience a growth from $33 Mn in 2022 to $68 Mn by 2030, with a CAGR of 9.6% during the forecast period of 2022-2030. High anemia prevalence across diverse demographics, rising healthcare spending with government initiatives, and evolving market dynamics with emerging treatment options all act as key drivers for the Philippine Anemia Therapeutics Market growth. The Philippines Anemia Therapeutics Market encompasses various players across different segments, including Novartis, Pfizer, Roche, Bayer, Sanofi, AstraZeneca, Johnson & Johnson, Unilab, Mercury Drug Corporation, Metro Drugs, etc, among various others.
Mexico Anemia Therapeutics Market Analysis
The Mexico Anemia Therapeutics Market is anticipated to experience a growth from $222 Mn in 2022 to $454 Mn by 2030, with a CAGR of 9.35% during the forecast period of 2022-2030. The market drivers for the Mexico Anemia Therapeutics Market include factors like increased awareness and early intervention driven by the risks of untreated anemia, the exploration of newer and more effective treatment options by pharmaceutical firms globally, and the impact of socio-economic factors contributing to a higher prevalence of anemia. The Mexico Anemia Therapeutics Market encompasses various players across different segments, including Abbott, Amgen, Johnson & Johnson, Roche, Pfizer, Biosan, Solfarma, Liomont Laboratories, Pisa Laboratories, Genomma Lab International etc, among various others.
Malaysia Anemia Therapeutics Market Analysis
The Malaysia Anemia Therapeutics Market is anticipated to experience a growth from $24 Mn in 2022 to $48 Mn by 2030, with a CAGR of 9.3% during the forecast period of 2022-2030. The government's deliberate focus on maternal and child health initiatives that address iron deficiency anemia, as well as the creation of business opportunities, treatment demand, and the expansion of healthcare coverage to improve treatment accessibility, are the main factors driving the Malaysian market. The Malaysia Anemia Therapeutics Market encompasses various players across different segments, including Novartis, Roche, Pfizer, Johnson & Johnson, AbbVie, Duopharma, Pharmaniaga, Mead Johnson Malaysia, Baxter International, Fresenius Medical Care, etc, among various others.
Kenya Anemia Therapeutics Market Analysis
The Kenya Anemia Therapeutics Market is anticipated to experience growth from $10 Mn in 2022 to $23 Mn by 2030, with a CAGR of 10.2% during the forecast period of 2022-2030. The growth of the Kenya anemia therapeutics market is primarily propelled by the high burden of anemia, particularly among pregnant women and young children, along with government initiatives, awareness programs, and increased accessibility to diagnostic testing and affordable treatment options. The Kenya Anemia Therapeutics Market encompasses various players across different segments, including Pfizer, Novartis, Sanofi, GlaxoSmithKline (GSK), AstraZeneca, Bayer, Amgen, Cipla, Pharmchem, Alphapharm, Medisys Laboratories etc, among various others.
Japan Anemia Therapeutics Market Analysis
The Japan Anemia Therapeutics Market is anticipated to experience a growth from $0.92 Bn in 2022 to $1.915 Bn by 2030, with a CAGR of 9.6% during the forecast period of 2022-2030. Japan's aging population, at the forefront of global life expectancy, prompts demand for specialized anemia therapies due to increased risks, while the nuanced market segments and supportive societal and economic factors further contribute to strategic considerations and overall growth. The Japan Anemia Therapeutics Market encompasses various players across different segments, including Pfizer, Novartis, Bayer, FibroGen, AstraZeneca, Eisai Co., Chugai Pharmaceuticals, Otsuka, Kyowa Hakko Kirin, Zeria Pharmaceuticals, etc, among various others
Indonesia Anemia Therapeutics Market Analysis
The Indonesia Anemia Therapeutics Market is anticipated to experience a growth from $89 Mn in 2022 to $178 Mn by 2030, with a CAGR of 9.1% during the forecast period of 2022-2030. The key drivers of the Indonesia Anemia Therapeutics Market include a greater emphasis on preventative treatment with better support from the government, and growing affordability and market access to anti-anemic drugs. The Indonesia Anemia Therapeutics Market encompasses various players across different segments, including Novartis, Roche, Bayer, Pfizer, GlaxoSmithKline (GSK), Kalbe Farma, Indofarma, Kimia Farma, Sanbe Farma, Pharos Indonesia, etc, among various others
Germany Anemia Therapeutics Market Analysis
The Germany Anemia Therapeutics Market is anticipated to experience a growth from $542 Mn in 2022 to $952 Mn by 2030, with a CAGR of 7.30 % during the forecast period of 2022-2030. The key drivers for market growth in Germany's healthcare sector are the aging population, advances in diagnosis and treatment, and growing awareness with increased patient empowerment. The Germany Anemia Therapeutics Market encompasses various players across different segments, including Amgen, AbbVie, Roche, Pfizer, AstraZeneca, Novartis, 1A Pharma, 3B Pharmaceuticals, AbZ-Pharma, Dr. Reddy's Laboratories, etc, among various others.
France Anemia Therapeutics Market Analysis
The France Anemia Therapeutics Market is anticipated to experience a growth from $407 Mn in 2022 to $759 Mn by 2030, with a CAGR of 8.10 % during the forecast period of 2022-2030. Higher prevalence owing to unhealthy lifestyles, initiatives to eliminate societal stigma associated with specific anemias, and improvements in technologies like as gene therapy, gene editing, and innovative medication delivery techniques are among the factors driving market growth. The France Anemia Therapeutics Market encompasses various players across different segments, including Sanofi, Amgen, Novartis, AstraZeneca, Spark Therapeutics, Bluebird Bio, Emmaus Medical, Mylan, Sandoz, Institut Mérieux etc, among various others.
Egypt Anemia Therapeutics Market Analysis
The Egypt Anemia Therapeutics Market is anticipated to experience a growth from $41 Mn in 2022 to $93 Mn by 2030, with a CAGR of 10.6% during the forecast period of 2022-2030. The key drivers for the growth of the Egypt Anemia Therapeutics Market include continuous advancements in pharmaceuticals for enhanced treatment options, a high prevalence of anemia types, particularly IDA, thalassemia, and SCA, necessitating diverse and specific therapies, and growing government initiatives focused on improving healthcare accessibility. The Egypt Anemia Therapeutics Market encompasses various players across different segments, including Novartis, Pfizer, Sanofi, Abbott Laboratories, Teva Pharmaceuticals, Foresee Pharmaceuticals, Jasper Therapeutics, Amoun Pharmaceutical Company, Pharco Pharmaceuticals, Hikma Pharmaceuticals, etc, among various others.
China Anemia Therapeutics Market Analysis
The China Anemia Therapeutics Market is anticipated to experience a growth from $1.19 Bn in 2022 to $2.664 Bn by 2030, with a CAGR of 10.6% during the forecast period of 2022-2030. The aging population's increased risk of anemia from chronic illnesses, the burden of chronic diseases, rising disposable income that drives up healthcare expenditure, and improved awareness and early detection of anemia are the main drivers in China. The China Anemia Therapeutics Market encompasses various players across different segments, including Pfizer, Roche, GlaxoSmithKline (GSK), Novartis, Sanofi, Amgen, Jiangsu Hengrui Medicine, Guangzhou Baiyunshan Pharmaceutical, Sinopharm Group, Shanghai Pharmaceuticals, etc, among various others.
